Idogen - Crunchbase Company Profile & Funding
Idogen AB publicerar Årsredovisning för 2018
Idogen aktieägargrupp | Facebook
biotech | pharma | diagnostics | devices
Idogen's Historical Milestones - Idogen
Idogen presentation - Idogen
Idogen AB (publ) Org nr
biotech | pharma | diagnostics | devices
Idogen - Crunchbase Company Profile & Funding
Board and Advisors | Ambulero
Idogen's cell technology successfully advanced to large-scale production
Idogen AB (publ) Corp. Reg. No.
Investors Home
PRESS RELEASE IDOGEN AB
Idogen will be listed on Nasdaq First North Growth Market on June 4, 2020
Idogen files patent application for new tolerogenic cell therapy
Noteringar i veckan
BioInsights - Bringing advanced therapies to the clinic: the Swedish National ATMP Consortium (CAMP/SWElife ATMP)
Idogen AB Year-end report
Idogen - Engineering Immune Tolerance
Trading Direkt analyserar bolagen på Spotlight 2018-10-18: Plejd & Idogen - YouTube
Idogen AB | Aktiespararna
Q3 ENG - Idogen
Idogen AB | Aktiespararna
biotech | pharma | diagnostics | devices
Redeye-intervju med Idogens VD om emissionsutfallet och rekryteringen av ny CMO - IPO.se
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
